0000885590-11-000021.txt : 20110411 0000885590-11-000021.hdr.sgml : 20110408 20110411190057 ACCESSION NUMBER: 0000885590-11-000021 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20101222 FILED AS OF DATE: 20110411 DATE AS OF CHANGE: 20110411 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Loberg Philip Walden Jr CENTRAL INDEX KEY: 0001508799 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 11753583 MAIL ADDRESS: STREET 1: 31121 BROOKS STREET CITY: LAGUNA BEACH STATE: CA ZIP: 92651 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7150 MISSISSAUGA ROAD STREET 2: MISSISSAUGA CITY: ONTARIO STATE: A6 ZIP: 00000 BUSINESS PHONE: 905 286-3000 MAIL ADDRESS: STREET 1: 7150 MISSISSAUGA ROAD STREET 2: MISSISSAUGA CITY: ONTARIO STATE: A6 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 4/A 1 primary_doc.xml PRIMARY DOCUMENT X0303 4/A 2010-12-22 2010-12-27 0 0000885590 Valeant Pharmaceuticals International, Inc. VRX 0001508799 Loberg Philip Walden Jr C/O 7150 MISSISSAUGA ROAD MISSISSAUGA A6 L5N 8M5 ONTARIO, CANADA 0 1 0 0 EVP, Interim CFO Common Stock, no par value 2010-12-22 4 A 0 694 0 A 130065 D Represents dividend equivalents accrued on performanced bases restricted share units (PSUs) as a result of a dividend paid on the common stock of Valeant Pharmaceuticals International, Inc. on December 22, 2010. This amendment is being filed to correct the number of PSUs that were reported in the original filing. By: Angie Palmer for Philip Loberg 2011-04-11